Clene Inc. (CLNN) Year-over-year net earnings per share growth for the last 12 months
Clene Inc. (CLNN) price action is driven by a dependence on investment in the absence of current revenues, as confirmed by the quarterly EPS growth rate, where this metric equals 106.20. The company is implementing AI-driven robotic nanocrystal synthesis to minimize manual labor. The strategy is based on gold nanoparticles to combat ALS and multiple sclerosis by supporting neuronal metabolism.
Analytical breakdowns and data insights for company Clene Inc. (CLNN)
- share price and expert price forecast:
- market capitalization details:
- book capitalization indicators:
- business debt structure and liquidity details:
- earnings and valuation multiples indicators:
CLNN - Company Profit|Expected Profit Clene Inc.|CLNN - Price to Earnings Multiple|Future Price to Earnings clene.com|CLNN - Growth-Adjusted P/E Ratio|EV/EBITDA Multiple Clene Nanomedicine|CLNN - Profit before interest, taxes and amortization|Net earnings per share for the last 12 months Clene|CLNN - Net earnings per share (EPS TTM)|Year-over-year earnings per share growth for the last twelve months clene.com|CLNN - Earnings per share increase in current year|Net earnings per share growth forecast for next year Clene Inc.
Analysis of all company metrics:Clene Inc - CLNN
The investment attractiveness of Clene Inc. (CLNN) depends on the biotech startup's ability to sustain funding for clinical trials in the absence of commercial sales. This indicator mathematically correlates current net earnings per share with target expansion rates, allowing for an assessment of the company's burn rate and fundamental stability through the history of quarterly EPS changes.
Main competitors
BIIB: Quarterly EPS earnings growth|Earnings per share growth in annualized terms for the last twelve months Neurocrine (NBIX)|Year-over-year net earnings per share growth for the last 12 months RGC|AXSM: Year-over-year earnings per one share growth for the last 12 months|Quarterly EPS earnings growth ACAD|Year-over-year net earnings per share change for the last twelve months xenon-pharma.com|Year-over-year earnings per share growth for the last twelve months Viking Therapeutics, Inc. VKTX|SUPN: Year-over-year earnings per share growth for the last 12 months|Catalyst Pharmaceuticals Inc - Quarterly EPS earnings growth|Denali Corp (DNLI) - Year-over-year net earnings per share growth for the last 12 months|HRMY (Harmony Biosciences) - Year-over-year net earnings per share growth for the last 12 months|BHVN - Year-over-year net earnings per share change for the last twelve months|AMLX (Amylyx Pharmaceuticals, Inc.) - Quarterly EPS earnings growth|Year-over-year net earnings per share growth for the last 12 months Trevi Therapeutics Inc (TRVI)|Year-over-year earnings per share growth for the last twelve months Praxis Medicines (PRAX)|Year-over-year earnings per share growth for the last twelve months AVXL (Anavex Life Sciences Corp)|Year-over-year earnings per share growth for the last twelve months CeriBell, Inc. CBLL|PRTA: Year-over-year earnings per share growth for the last 12 months|ALEC - Year-over-year earnings per share growth for the last twelve months|ANNX (Annexon Biosciences) - Year-over-year earnings per share growth for the last 12 months|omeros.com (OMER) - Year-over-year earnings per share growth for the last twelve months|Year-over-year earnings per share growth for the last 12 months NGNE|ACIU (AC Immune) - Quarterly EPS earnings growth|Earnings per share growth in annualized terms for the last twelve months voyagertherapeutics.com VYGR|Year-over-year net earnings per share growth for the last 12 months NMRA (Neumora Therapeutics, Inc.)|Quarterly EPS earnings growth Scilex Holding (SCLX)|Year-over-year earnings per share growth for the last twelve months Tevogen Bio Holdings, Inc. TVGN|Year-over-year earnings per one share growth for the last 12 months ACOG|CGTX - Year-over-year earnings per share growth for the last twelve months|Earnings per share growth in annualized terms for the last twelve months inhibikase.com|SAVA: Quarterly EPS earnings growth|Year-over-year net earnings per share growth for the last 12 months Assertio|Year-over-year earnings per share growth for the last twelve months Coya Therapeutics Inc|Year-over-year earnings per share growth for the last twelve months VTGN|Quarterly EPS earnings growth OVID|ABOS - Earnings per share growth in annualized terms for the last twelve months|Year-over-year earnings per share growth for the last twelve months CervoMed CRVO|ATHE: Year-over-year earnings per share growth for the last 12 months|PepGen Corp - Quarterly EPS earnings growth|Earnings per share growth in annualized terms for the last twelve months jupiterneurosciences.com|RLMD (Relmada Therapeutics) - Year-over-year net earnings per share growth for the last 12 months|annovisbio.com - Year-over-year earnings per one share growth for the last 12 months|GRCE (Grace Therapeutics Inc) - Quarterly EPS earnings growth|Firefly Neuroscience, Inc. (AIFF) - Year-over-year net earnings per share change for the last twelve months|Year-over-year earnings per share growth for the last twelve months Klotho Neurosciences Inc (KLTO)|neurosense-tx.com - Year-over-year earnings per share growth for the last 12 months|Quarterly EPS earnings growth RVPH (Reviva Pharmaceuticals)|MTVA - Year-over-year net earnings per share growth for the last 12 months|NRXS: Year-over-year net earnings per share growth for the last 12 months|Year-over-year net earnings per share change for the last twelve months Helius Medical HSDT|PASG: Quarterly EPS earnings growth|Year-over-year net earnings per share growth for the last 12 months Neuphoria Therapeutics|Year-over-year earnings per share growth for the last twelve months Minerva Neurosciences|Year-over-year earnings per share growth for the last twelve months ATHA|Year-over-year earnings per share growth for the last twelve months Addex Therapeutics Ltd (ADXN)|alzamend.com - Year-over-year earnings per share growth for the last 12 months|Year-over-year earnings per share growth for the last twelve months Cyclerion Therapeutics, Inc. CYCN|PTIX: Year-over-year earnings per share growth for the last 12 months|KTTA - Year-over-year earnings per share growth for the last twelve months|CRGT (Cortigent, Inc.) - Year-over-year earnings per share growth for the last 12 months|ATXI: Quarterly EPS earnings growth|Earnings per share growth in annualized terms for the last twelve months Brainstorm Cell Therapeutics Inc. (BCLI)|Year-over-year net earnings per share growth for the last 12 months CARA|Quarterly EPS earnings growth Chromocell|Year-over-year earnings per share growth for the last twelve months Eliem Therapeutics (ELYM)|ITCI (intracellulartherapies.com) - Year-over-year earnings per one share growth for the last 12 months|Year-over-year earnings per share growth for the last twelve months Longboard Pharmaceuticals, Inc. LBPH|Marinus Pharmaceuticals Inc (MRNS) - Earnings per share growth in annualized terms for the last twelve months|NKGen - Quarterly EPS earnings growth|NeuroBo Pharma (NRBO) - Year-over-year net earnings per share growth for the last 12 months|Sage Therapeutics, Inc. (SAGE) - Year-over-year earnings per share growth for the last twelve months|SNPX (synaptogen.com) - Year-over-year earnings per share growth for the last twelve months|TRVN (Trevena) - Quarterly EPS earnings growth|Earnings per share growth in annualized terms for the last twelve months Vigil Neuro VIGL|Year-over-year earnings per share growth for the last twelve months Anew Medical, Inc. (WENA)|Cerevel Corp - Year-over-year earnings per share growth for the last 12 months
